COMP <GO>
HWM vs TMO // PIOTROSKI F-SCORE QUALITY
Howmet Aerospace Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: HWM 7
— TMO 7
▲ PIOTROSKI F-SCORE QUALITY LEADER: HWM
LAST: $199.22 (-3.26%) • MKT CAP: $82.13B
piotroski-score
9/9
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
piotroski-score
8/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HWM VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HWM | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 21.60% | 9.30% | +12.30 | HWM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 34.7x | 30.4x | +4.30 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 1.74% | 2.40% | -0.66 | TMO | /fcf-yield <GO> |
| Operating Margin | 24.80% | 17.40% | +7.40 | HWM | /operating-margins <GO> |
| Net Profit Margin | 18.30% | 15.10% | +3.20 | HWM | /net-margins <GO> |
| Revenue Growth (YoY) | 11.10% | 3.90% | +7.20 | HWM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 10.53 | 4.50 | +6.03 | HWM | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 9/9 | 8/9 | +1.00 | HWM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.70% | +0.50 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.7 | 59.1 | -20.46 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | 0.94 | +0.16 | HWM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 50.7x | 36.3x | +14.40 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $82.13B | $262.22B | -$180.09B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HWM REV | TMO REV | HWM GROSS % | TMO GROSS % | HWM FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.25B | $44.56B | 44.0% | 44.0% | $1.43B | $6.29B |
| FY 2024 | $7.43B | $42.88B | 44.0% | 44.0% | $977.0M | $7.27B |
| FY 2023 | $6.64B | $42.86B | 44.0% | 44.0% | $602.2M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HWM // BETA 1.10
TMO // BETA 0.94